JPH045004B2 - - Google Patents
Info
- Publication number
- JPH045004B2 JPH045004B2 JP58194732A JP19473283A JPH045004B2 JP H045004 B2 JPH045004 B2 JP H045004B2 JP 58194732 A JP58194732 A JP 58194732A JP 19473283 A JP19473283 A JP 19473283A JP H045004 B2 JPH045004 B2 JP H045004B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- extracting
- organic solvent
- skin
- skin preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000012071 phase Substances 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000003495 polar organic solvent Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000000706 filtrate Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 239000006071 cream Substances 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000299452 Gouania lupuloides Species 0.000 description 2
- 235000000292 Gouania lupuloides Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000249820 Lipotes vexillifer Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940021231 clearskin Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000002031 ethanolic fraction Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 239000012629 purifying agent Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、皮膚外用剤における薬用効果を保持
しつつ、皮膚への塗布性、吸収性を改善し、更に
は皮膚水分保持機能をも付与し得る新規な乳化型
皮膚外用剤に関するものである。
古来より、当帰は強壮、鎮静、通経薬として白
〓は鎮痛、止血、排膿、浄血薬として、また紫根
は解毒、解熱薬として漢方の療法に広く利用され
てきた。そしてこれらの使用にあたつては煎剤等
の用法をもつて熱水で抽出し、その抽出液を内服
するという方法が通常であつた。但し、中国では
白〓、当帰等を油脂で抽出し、軟膏として使用し
ていた事例が幾つか見うけられ、一方日本におい
ても紫根と当帰を油脂で抽出し軟膏として使用す
る紫雲膏と呼ばれるものがあつた。
しかしこれら公知の軟膏群は何れも油脂をもつ
て抽出する為、本発明者らの研究によつて抽出成
分中には、抗菌性、抗炎症性を有する成分は存在
するものの、余効、例えば皮膚水分保持作用、湿
潤作用等を成分は全く存在しないことが突止めら
れていた。
一方、前記漢方療法においても内服を中心とし
た適用であつた為、その成分の外用的(特に皮膚
に対して)効能については、ほとんど研究すらさ
れていないのが実情であつた。
そこで本発明者らは、この皮膚に対する前記3
種の生薬の効能を詳細に調べたところ、抽出溶媒
として50〜80%エタノールを用た分画抽出物中
に、皮膚の水分を保持し、潤いを与える成分が存
在することを見出した。更に、皮膚外用剤として
の効能をより発揮させる為、前記3種の生薬を水
と相溶性のほとんどない有機溶媒で抽出し、その
成分を油相中に、また上記50〜80%エタノール分
画抽出物を水相中にそれぞれ含有させ、これらを
混合乳化することにより優れた皮膚外用剤が得ら
れることを知り本発明を完成させたものである。
本発明は当帰、白〓、紫根より選択される1種
または2種以上の生薬を極性の低い有機溶媒で抽
出処理して得られた粘稠状エキスを含有する油相
と、該生薬を50〜80%エタノールで抽出処理して
得られた粉末状抽出物を含有する水相とを、混合
乳化してなる乳化型皮膚外用剤に関するものであ
る。
本発明において油相中に含有される粘稠状エキ
スは次のような方法で調整される。すなわち先ず
当帰、白〓、紫根の3種の生薬から目的に応じて
任意に1種乃至は2種以上を選択し、これを水と
相溶性のほとんどない例えばベンゼン、n−ヘキ
サン、クロロホルム、エーテル等の極性の低い有
機溶媒の単独もしくは混合溶媒中で温浸抽出し、
ロ過したロ液を適宜な方法により濃縮乾固して得
られる。これを通常の乳化の際油相として用いる
エーテル類、エステル類、炭化水素類に溶解し、
これを乳化物の油相として用いる。
また、水相中に含有される粉末状抽出物の調整
法は以下の通りである。前記3種の生薬を50〜80
%エタノールで常温下または温浸下抽出処理し、
ロ過したロ液を濃縮すると皮膚の水分を保ち潤い
を与える成分を含んだものが得られる。しかし、
経済的(コスト的)観点から見た時には、生薬か
ら単独に50〜80%エタノール抽出するよりも、前
記極性の低い有機溶媒による抽出した後の抽出残
渣を用いることがより有利であり、また抽出効率
をより高める為には次のような別法に従がうのが
より実際的である。即ち、生薬を極性の低い有機
溶媒で抽出処理し、ロ過後、残渣を水または熱水
で充分に再抽出する。その後ロ過し、ロ液を操作
上便利な程度まで濃縮する。次いでこれにアルコ
ールを加え、そのアルコール濃度が50〜80%にな
るように調整する。すると不溶物(このものには
水分保持能がほとんどない)が沈殿してくるので
これをロ過し、ロ液を集め濃縮乾固すると上述と
同じ成分を含有したものが得られる。
以上の様にして得られた抽出物の水分保持機能
を評価する為、本発明者らは人の足より剥離した
角層を用い下記の1)、2)の方法によりその効
果を検定した。その結果については表−1及び2
に示す。
1) 抽出物を用いた測定
Γ試料:A 水可溶、75%EtOH不溶部分(沈
殿物)
B 水及び75%EtOH可溶部分
C 尿素(対照)
D 水(コントロール)
Γ方法:厚さ0.5mm、直径1cmの錠剤にプレス
した貝層を、上記A、B、Cの5%
水溶液及びD中に30分間浸漬し、次
いで余分な液をテイツシユペーパー
で軽く拭き取り、これを20℃、93%
の一定温湿度下に放置し、5日後の
角層100mg当りに水分残存(保持)
量を測定した。n=5。
2) 抽出物を含有するクリームを用いた測定
Γ試料:a n−ヘキサン抽出エキスを2wt%
含有したクリーム
b 水可溶、75%EtOH不溶部分(沈
殿物)を5wt%含有したクリーム
c 水及び75%EtOH可溶部分を5wt
%含有したクリーム
d a及びcの両成分を含有(7wt
%)したクリーム(本発明品)
Γ方法:1)の方法と同様にして行なつた。n
=5。
The present invention relates to a novel emulsified skin preparation that maintains the medicinal effects of the skin preparation, improves its applicability to the skin and absorbability, and can also provide skin moisture retaining function. Since ancient times, dangki has been widely used in Chinese medicine as a tonic, sedative, and emmenagogue; baiji as an analgesic, hemostasis, purulent, and purifying agent; and purple root as a detoxifying and antipyretic agent. The usual method for using these substances was to make a decoction, extract them with hot water, and then take the extract internally. However, in China, there are some cases of extracting white root, danggui, etc. with oil and using it as an ointment, and on the other hand, in Japan, there are also cases of extracting white root and danggui with oil and using it as an ointment. There was something called. However, since all of these known ointments are extracted with fats and oils, research by the present inventors has shown that although there are components in the extracted components that have antibacterial and anti-inflammatory properties, there are no residual effects, such as It has been determined that there are no ingredients that have skin moisture retaining or moisturizing effects. On the other hand, since the above-mentioned Chinese herbal therapy was mainly applied internally, the actual efficacy of its ingredients externally (particularly on the skin) has hardly been studied. Therefore, the present inventors developed the above-mentioned three methods for this skin.
A detailed study of the efficacy of the herbal medicine from the species revealed that a fractionated extract using 50-80% ethanol as the extraction solvent contains components that retain moisture and moisturize the skin. Furthermore, in order to further demonstrate the effectiveness of the topical skin preparation, the three herbal medicines mentioned above were extracted with an organic solvent that has little compatibility with water, and the components were added to the oil phase and the 50-80% ethanol fraction mentioned above. The present invention was completed based on the knowledge that an excellent external preparation for skin can be obtained by incorporating each extract into an aqueous phase and mixing and emulsifying these. The present invention provides an oil phase containing a viscous extract obtained by extracting one or more herbal medicines selected from Toki, Shiro, and Shikon with a low polar organic solvent, and This invention relates to an emulsified skin preparation prepared by mixing and emulsifying an aqueous phase containing a powdered extract obtained by extraction with 50 to 80% ethanol. In the present invention, the viscous extract contained in the oil phase is prepared by the following method. That is, first, one or two or more of the three herbal medicines, Toki, Shiro, and Shikon, are arbitrarily selected depending on the purpose, and these are mixed with benzene, n-hexane, chloroform, etc., which have little compatibility with water. Digestion extraction in a low polar organic solvent such as ether or a mixed solvent,
The filtered filtrate is concentrated to dryness using an appropriate method. This is dissolved in ethers, esters, and hydrocarbons used as the oil phase during normal emulsification,
This is used as the oil phase of the emulsion. Further, the method for preparing the powdered extract contained in the aqueous phase is as follows. 50 to 80 doses of the above three herbal medicines
% ethanol at room temperature or digestion treatment,
When the filtered filtrate is concentrated, it contains ingredients that retain and moisturize the skin. but,
From an economic (cost) perspective, it is more advantageous to use the extraction residue after extraction with the organic solvent with low polarity than to extract 50 to 80% ethanol from herbal medicines alone. In order to further increase efficiency, it is more practical to follow the following alternative method. That is, the crude drug is extracted with a less polar organic solvent, and after filtration, the residue is sufficiently re-extracted with water or hot water. It is then filtered and the filtrate is concentrated to an operationally convenient degree. Next, add alcohol to this and adjust the alcohol concentration to 50-80%. Then, insoluble matter (which has almost no water retention ability) precipitates, which is filtered, and the filtrate is collected and concentrated to dryness to obtain a product containing the same components as mentioned above. In order to evaluate the water retention function of the extract obtained as described above, the present inventors used the stratum corneum exfoliated from human feet to test its effectiveness according to methods 1) and 2) below. Tables 1 and 2 for the results.
Shown below. 1) Measurement using extract Γ sample: A Water soluble, 75% EtOH insoluble part (precipitate) B Water and 75% EtOH soluble part C Urea (control) D Water (control) Γ method: Thickness 0.5 The shell layer pressed into tablets with a diameter of 1 cm and 5% of the above A, B, and C
Immerse it in the aqueous solution and D for 30 minutes, then wipe off the excess liquid with tissue paper, and store it at 20℃ and 93%
After 5 days, moisture remains (retention) per 100mg of stratum corneum after leaving it under constant temperature and humidity.
The amount was measured. n=5. 2) Measurement using cream containing extract Γ sample: 2wt% a n-hexane extract
Cream B containing 5wt% of water soluble and 75% EtOH insoluble portion (precipitate) Cream C containing 5wt% of water and 75% EtOH soluble portion
Contains both ingredients A and C (7 wt.
%) cream (product of the present invention) Γ method: This was carried out in the same manner as in 1). n
=5.
【表】【table】
【表】【table】
【表】
表−1、2の結果が示すように、白〓、当帰、
紫根の水及び75%EtOH可溶抽出部分には明白な
皮膚水分保持効果があることがわかる。また表−
2のクリームd(本発明品)においても、水分保
持効果のいささかの減少も見られず、漢方軟膏が
持つている予想される作用を加味し優れた皮膚外
用剤を提供できるようになる。尚、念のため市販
の紫雲膏と本発明のクリームdとの創傷治癒効果
(治癒率、治癒日数)の比較検討をウサギを用い
て測定したところ紫雲膏と同等乃至はそれ以上の
効果が見られた。
本発明により得られた乳化型皮膚外用剤は、更
に以下に挙げる如き利点及び特徴を有するもので
ある。
(1) 今までの漢方軟膏は硬く適量をとりずらく、
皮膚の表面に均一に塗布しにくかつたが乳化す
ることによりこの欠点は解消された。
(2) 漢方の軟膏は油脂で高温で抽出することによ
り油脂の酸化が促進され皮膚に悪い作用を及ぼ
すPOV値の上昇が見られたが今回これが解消
された。
(3) 乳化することにより、薬効成分の吸収がよく
ない生薬の使用量を軟膏の時より減らすことが
出来るようになつた。
以下に本発明の実施例を示す。尚、処方中の配
合割合はそれぞれ重量部である。
実施例 1
クリーム
当帰100g、白〓100gを混合し、ヘキサン1
で2回温浸し、ロ過したロ液を濃縮乾固しこれを
エキス1とする。次にロ過した残渣を熱水1.5
で2回抽出し、ロ過したロ液を適当に濃縮し、ア
ルコールを加えてその濃度が80%とならるように
調製する。次に沈殿したものをロ過し、ロ液を濃
縮乾固し、エキス2とする。
これらエキス1、エキス2を次に示すクリーム
処方中にそれぞれ配合し乳化する。
油相
蜜ロウ 9.0
流動パラフイン 20.0
ラノリン 3.0
半硬化植物油 25.0
ソルビタンステアレート 5.0
ソルビタンステアレート−ポリオキエチレ
ン−エーテル 2.0
エキス1 2.0
水相
水 28.0
エキス2 5.0
ホウ砂 0.7
防腐剤 適量
香 料 適量
実施例 2
乳 液
当帰、白〓、紫根を70gずつ取り混合する。混
合物をエーテル1で2回温浸し、ロ過しロ液を
濃縮乾固し、エキス1とする。次に残渣を熱水
1.5で2回抽出し、ロ液を適当に濃縮し、アル
コールを加え、その濃度が70%となるように調製
する。これをロ過し、ロ液を濃縮乾固し、エキス
2とする。これらエキス1、及び2を下に示す乳
液処方向中にそれぞ配合し乳化する。
油相
ステアリン酸 3.2
エキス1 1.0
水相
グリセリン 6.0
アミノ酸 0.3
水 75.5
アルコール 8.5
トラガントガム 2.0
エキス2 3.0
防腐剤 適量
香 料 適量[Table] As the results in Tables 1 and 2 show, white
It can be seen that the water and 75% EtOH soluble extract of purple root has a clear skin moisture retention effect. Also table-
Even in Cream d (product of the present invention) of No. 2, no decrease in the moisture retention effect was observed, and an excellent external skin preparation could be provided by taking into account the expected effects of Chinese herbal ointments. As a precaution, we compared the wound healing effects (healing rate, healing days) of commercially available Shiun Gypsum and Cream d of the present invention using rabbits, and found that it was as effective as or even more effective than Shiun Gypsum. It was done. The emulsified skin preparation obtained by the present invention further has the following advantages and characteristics. (1) Traditional Chinese herbal ointments are hard and difficult to take in the right amount.
Although it was difficult to apply it uniformly to the skin surface, this drawback was overcome by emulsification. (2) Extraction of Chinese herbal ointments with fats and oils at high temperatures promotes oxidation of the fats and oils, leading to an increase in the POV value, which has a negative effect on the skin, but this problem has been resolved. (3) By emulsifying it, the amount of herbal medicines whose medicinal ingredients are poorly absorbed can be reduced compared to when using ointments. Examples of the present invention are shown below. Incidentally, the proportions in the formulation are in parts by weight. Example 1 Mix 100g of cream and 100g of white cream, add 1 part of hexane
The filtrated filtrate was concentrated to dryness and used as Extract 1. Next, pour the filtered residue into 1.5 liters of hot water.
The filtrate is extracted twice and the filtrate is appropriately concentrated, and alcohol is added to adjust the concentration to 80%. Next, the precipitate is filtered, and the filtrate is concentrated to dryness to obtain Extract 2. These Extract 1 and Extract 2 are each blended into the following cream formulation and emulsified. Oil phase Beeswax 9.0 Liquid paraffin 20.0 Lanolin 3.0 Semi-hardened vegetable oil 25.0 Sorbitan stearate 5.0 Sorbitan stearate-polyoxyethylene-ether 2.0 Extract 1 2.0 Aqueous phase Water 28.0 Extract 2 5.0 Borax 0.7 Preservatives Appropriate amount Fragrance Appropriate amount Example 2 Milk Lotion Take 70g each of Toki, Shiro, and Shikon and mix. The mixture is digested twice with ether 1, filtered and the filtrate is concentrated to dryness to obtain extract 1. Then soak the residue in hot water
Extract twice with 1.5, concentrate the filtrate appropriately, and add alcohol to adjust the concentration to 70%. This is filtered, and the filtrate is concentrated to dryness to obtain Extract 2. These extracts 1 and 2 are blended into the emulsion formulation shown below and emulsified. Oil phase Stearic acid 3.2 Extract 1 1.0 Aqueous phase Glycerin 6.0 Amino acids 0.3 Water 75.5 Alcohol 8.5 Gum tragacanth 2.0 Extract 2 3.0 Preservatives Appropriate amount Flavoring Appropriate amount
Claims (1)
2種以上の生薬を極性の低い有機溶媒で抽出処理
して得られた粘稠状エキスを含有する油相と、該
生薬を50〜80%エタノールで抽出処理して得られ
た粉末状抽出物を含有する水相とを、混合乳化し
てなる乳化型皮膚外用剤。 2 極性の低い有機溶媒がベンゼン、n−ヘキサ
ン、クロロホルム、エーテル等より選択される1
種または2種以上の混合物である特許請求の範囲
第1項記載の乳化型皮膚外用剤。 3 粉末状抽出物が生薬を極性の低い有機溶媒で
抽出処理して得られた抽出残渣を50〜80%エタノ
ールで再抽出処理して得られたものである特許請
求の範囲第1項記載の乳化型皮膚外用剤。[Scope of Claims] 1. An oil phase containing a viscous extract obtained by extracting one or more crude drugs selected from Toki, Shiro, and Shikon with a low polar organic solvent; An emulsified skin preparation prepared by mixing and emulsifying the crude drug with an aqueous phase containing a powdered extract obtained by extracting the crude drug with 50 to 80% ethanol. 2 The organic solvent with low polarity is selected from benzene, n-hexane, chloroform, ether, etc. 1
The emulsified skin preparation for external use according to claim 1, which is a species or a mixture of two or more species. 3. The powdered extract is obtained by re-extracting the extraction residue obtained by extracting the crude drug with a low polarity organic solvent with 50 to 80% ethanol. Emulsified skin preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58194732A JPS6087224A (en) | 1983-10-18 | 1983-10-18 | Emulsion-type dermatic drug for external use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58194732A JPS6087224A (en) | 1983-10-18 | 1983-10-18 | Emulsion-type dermatic drug for external use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6087224A JPS6087224A (en) | 1985-05-16 |
| JPH045004B2 true JPH045004B2 (en) | 1992-01-30 |
Family
ID=16329309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58194732A Granted JPS6087224A (en) | 1983-10-18 | 1983-10-18 | Emulsion-type dermatic drug for external use |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6087224A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60199807A (en) * | 1984-03-22 | 1985-10-09 | Kao Corp | Humectant |
| JPS60258104A (en) * | 1984-06-06 | 1985-12-20 | Inahata Koryo Kk | Cosmetic composition having moisture retention |
| WO2003086433A1 (en) * | 2002-04-15 | 2003-10-23 | Tetsuo Santo | Therapeutic cream for dermatitis |
| CN100340283C (en) | 2002-04-15 | 2007-10-03 | 山东哲夫 | Therapeutic lotion for dermatitis |
| CN103027863B (en) * | 2011-09-30 | 2015-02-25 | 伽蓝(集团)股份有限公司 | Microemulsion containing peony extracts as well as preparation method and application of microemulsion |
| CN102697857B (en) * | 2012-05-29 | 2014-04-16 | 株洲千金药业股份有限公司 | Maternal towel liquid medicament for preventing puerperal infection and preparation method thereof |
| CN112156128B (en) * | 2020-11-11 | 2022-07-22 | 苏州健雄职业技术学院 | Preparation method of multi-effect lithospermum paste for infants |
-
1983
- 1983-10-18 JP JP58194732A patent/JPS6087224A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6087224A (en) | 1985-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100496579C (en) | Antipruritic compositions and compositions for wound healing | |
| JPS60156618A (en) | Cosmetic or medicinal composition based on plant extract | |
| JPH0140002B2 (en) | ||
| JPH02180827A (en) | Use of tocopherol, benzyl, chisantinol or hexyl nicotinate or tocopherol acetate | |
| JPS6351126B2 (en) | ||
| WO1999003485A1 (en) | External preparations containing watercress extract | |
| JPH045004B2 (en) | ||
| EP0234143B1 (en) | Galenical forms based on fresh plants, and process for their preparation | |
| JPS5811922B2 (en) | Keshiyouriyo | |
| JP2501593B2 (en) | Topical agent for suppressing melanin production | |
| RU2076699C1 (en) | Antimastopathy ointment | |
| JPH01117816A (en) | Cosmetic | |
| JPS6046086B2 (en) | Cosmetics containing goshiyuyu extract | |
| RU2469704C1 (en) | Regenerin serum for external application with anti-inflammatory and regenerative effect | |
| CN108853369B (en) | Preparation method and application of natural plant antibacterial liquid PAMs hydrogel patch | |
| JPH0273020A (en) | Analgesic and anti-inflammatory agent for transcutaneous administration | |
| JP2009521425A (en) | Therapeutic and cosmetic balsam | |
| RU2248198C2 (en) | Anti-burn preparation | |
| JP2811479B2 (en) | Hair restoration | |
| JPH0212926B2 (en) | ||
| CN108938522B (en) | Makeup removing lotion containing PEG-12 monolaurate and preparation method thereof | |
| CN121337669A (en) | An anti-inflammatory and moisturizing skin cream containing willowherb extract and its preparation method | |
| JPS6322506A (en) | External preparation for skin | |
| JPH10182473A (en) | Subcutaneous fat metabolism promoter and external composition containing the same | |
| TR2023001181A2 (en) | CELL RENEWAL CREAM |